Similar articles for PMID: 34835501

Year	Number of Results
2013	1
2014	1
2015	2
2016	2
2017	3
2018	7
2019	5
2020	12
2021	20
2022	31
2023	27
2024	8

1

Probiotics Regulating Inflammation via NLRP3 Inflammasome Modulation: A Potential Therapeutic Approach for COVID-19.

Kasti AN, Synodinou KD, Pyrousis IA, Nikolaki MD, Triantafyllou KD. Kasti AN, et al. Microorganisms. 2021 Nov 17;9(11):2376. doi: 10.3390/microorganisms9112376. Microorganisms. 2021. PMID: 34835501 Free PMC article. Review.

2

Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.

Yong YY, Zhang L, Hu YJ, Wu JM, Yan L, Pan YR, Tang Y, Yu L, Law BY, Yu CL, Zhou J, Li M, Qin DL, Zhou XG, Wu AG. Yong YY, et al. Clin Immunol. 2022 Nov;244:109093. doi: 10.1016/j.clim.2022.109093. Epub 2022 Aug 6. Clin Immunol. 2022. PMID: 35944881 Free PMC article. Review.

3

Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.

Jahan S, Kumar D, Chaturvedi S, Rashid M, Wahajuddin M, Khan YA, Goyal SN, Patil CR, Mohanraj R, Subramanya S, Ojha S. Jahan S, et al. Curr Med Chem. 2017;24(16):1645-1670. doi: 10.2174/0929867324666170227121619. Curr Med Chem. 2017. PMID: 28245768 Review.

4

Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice.

Zeng J, Xie X, Feng XL, Xu L, Han JB, Yu D, Zou QC, Liu Q, Li X, Ma G, Li MH, Yao YG. Zeng J, et al. EBioMedicine. 2022 Jan;75:103803. doi: 10.1016/j.ebiom.2021.103803. Epub 2021 Dec 31. EBioMedicine. 2022. PMID: 34979342 Free PMC article.

5

Role of NLRP3 inflammasome in COVID-19 and periodontitis: Possible protective effect of melatonin.

Şehirli AÖ, Aksoy U, Koca-Ünsal RB, Sayıner S. Şehirli AÖ, et al. Med Hypotheses. 2021 Jun;151:110588. doi: 10.1016/j.mehy.2021.110588. Epub 2021 Mar 30. Med Hypotheses. 2021. PMID: 33848919 Free PMC article.

6

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein.

Albornoz EA, Amarilla AA, Modhiran N, Parker S, Li XX, Wijesundara DK, Aguado J, Zamora AP, McMillan CLD, Liang B, Peng NYG, Sng JDJ, Saima FT, Fung JN, Lee JD, Paramitha D, Parry R, Avumegah MS, Isaacs A, Lo MW, Miranda-Chacon Z, Bradshaw D, Salinas-Rebolledo C, Rajapakse NW, Wolvetang EJ, Munro TP, Rojas-Fernandez A, Young PR, Stacey KJ, Khromykh AA, Chappell KJ, Watterson D, Woodruff TM. Albornoz EA, et al. Mol Psychiatry. 2023 Jul;28(7):2878-2893. doi: 10.1038/s41380-022-01831-0. Epub 2022 Nov 1. Mol Psychiatry. 2023. PMID: 36316366 Free PMC article.

7

Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors.

Diarimalala RO, Wei Y, Hu D, Hu K. Diarimalala RO, et al. Front Cell Infect Microbiol. 2023 Jun 9;13:1218039. doi: 10.3389/fcimb.2023.1218039. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37360532 Free PMC article. Review.

8

NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity.

Amin S, Aktar S, Rahman MM, Chowdhury MMH. Amin S, et al. Microbes Infect. 2022 Feb;24(1):104913. doi: 10.1016/j.micinf.2021.104913. Epub 2021 Nov 25. Microbes Infect. 2022. PMID: 34838941 Free PMC article. Review.

9

The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.

Zhao N, Di B, Xu LL. Zhao N, et al. Cytokine Growth Factor Rev. 2021 Oct;61:2-15. doi: 10.1016/j.cytogfr.2021.06.002. Epub 2021 Jun 18. Cytokine Growth Factor Rev. 2021. PMID: 34183243 Free PMC article. Review.

10

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.

Lécuyer D, Nardacci R, Tannous D, Gutierrez-Mateyron E, Deva Nathan A, Subra F, Di Primio C, Quaranta P, Petit V, Richetta C, Mostefa-Kara A, Del Nonno F, Falasca L, Marlin R, Maisonnasse P, Delahousse J, Pascaud J, Deprez E, Naigeon M, Chaput N, Paci A, Saada V, Ghez D, Mariette X, Costa M, Pistello M, Allouch A, Delelis O, Piacentini M, Le Grand R, Perfettini JL. Lécuyer D, et al. Front Immunol. 2023 Oct 18;14:1270081. doi: 10.3389/fimmu.2023.1270081. eCollection 2023. Front Immunol. 2023. PMID: 37920468 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year